Read the press release from the FDA.

The U.S. Food and Drug Administration today [December 22] approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years.

Click here for the Gay Men’s Health Crisis press release on Gardasil for men.
 

[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article’s content, whether in support or in opposition.]